A joint Australian-Italian study has found traces of the anti-depressant fluoxetine in lakes and rivers, potentially affecting freshwater fish. The residue of medications like fluoxetine, which is often excreted in waste, may be absorbed by aquatic life. In a study of male guppies exposed to fluoxetine for five years, it was found that even low levels of the drug caused an increase in the size of the gonopodium and lower sperm mobility, impacting the fertility of the fish.
Other pharmaceuticals and contaminants have also been found in freshwater, including analgesics, antibiotics, microplastics, and heavy metals like arsenic. Scientists have called for modifications to water treatment processes to filter out these pollutants, emphasizing the need for government engagement and improved monitoring and compliance standards. While further research is needed to fully understand the impact of these contaminants on the environment, efforts to prevent pharmaceuticals and other pollutants from entering waterways are crucial.
The study highlights the need for increased awareness and action to address the presence of pharmaceuticals in freshwater environments. By improving water treatment processes and implementing stricter regulations, researchers hope to mitigate the negative effects of these contaminants on aquatic ecosystems. Ultimately, collaboration between scientists, governments, and international organizations is necessary to protect freshwater ecosystems from the harmful effects of pharmaceutical pollution.
Source
Photo credit www.aljazeera.com
